Irvine, California 92612


Purpose:

The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.


Study summary:

The researchers will evaluate changes in the dermis and skin properties as the effect of treatment with Tretinoin cream (0.1%) by using the following optical imaging techniques. 1. Multiphoton microscopy using a clinical tomograph (MPTflex, Jenlab, Germany) 2. Multispectral Imaging using a device developed at Beckman Laser Institute, UC Irvine


Criteria:

Inclusion Criteria: - Female 45 years of age or older - Skin type scale I to III Exclusion Criteria: - Large amount of dark, coarse hair on the arms - History of allergies to alpha hydroxy acids (AHAs), retinoids, soaps, fragrances, sunscreens or Latex - Currently using over-the-counter AHA or retinol within one month or prescription retinoid within three months of the start of the study. - History of skin cancer, including squamous or basal cell carcinoma at the treatment site or history of malignant melanoma. - History of diabetes - Currently pregnant or nursing


NCT ID:

NCT02410980


Primary Contact:

Principal Investigator
Mihaela Balu, PhD
Beckman Laser Institute, UCI

Mihaela Balu, PhD
Phone: 949.824.8797
Email: mbalu@uci.edu


Backup Contact:

Email: sharifs@uci.edu
Ata Sharif, MD
Phone: 949 824 9265


Location Contact:

Irvine, California 92612
United States

Mihaela Balu, PhD
Phone: 949-824-8797
Email: mbalu@uci.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.